# Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II)

Study · id `cardio:ct-nct01173094` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01173094](<https://clinicaltrials.gov/study/NCT01173094>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01173094

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

## Technical summary

Registry record NCT01173094. Non-randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT01173094, source copy `cardio:ctgov-nct01173094-2012-12-24`, retrieved 2026-10-26)
- Start date: 2010-08 (registry gives no type) (ClinicalTrials.gov record NCT01173094, source copy `cardio:ctgov-nct01173094-2012-12-24`, retrieved 2026-10-26)
- Primary completion: 2013-07 (anticipated) (ClinicalTrials.gov record NCT01173094, source copy `cardio:ctgov-nct01173094-2012-12-24`, retrieved 2026-10-26)
- Completion: 2016-07 (anticipated) (ClinicalTrials.gov record NCT01173094, source copy `cardio:ctgov-nct01173094-2012-12-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01173094, source copy `cardio:ctgov-nct01173094-2012-12-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01173094-2012-12-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II)
- Acronym: DCLI-II
- Condition: Vascular Diseases
- Condition: Diabetes
- Intervention (Device): Percutaneous Transluminal Angioplasty
- Intervention (Device): below-knee arterial bypass
- Lead sponsor: Peking Union Medical College Hospital
- Lead sponsor class: OTHER
- Collaborator: Beijing Tongren Hospital
- Collaborator class: OTHER
- Collaborator: Xuanwu Hospital, Beijing
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Peking Union Medical College Hospital (`cardio:org-peking-union-medical-college-hospital`)
- Registry lists this organization as a collaborator: Beijing Tongren Hospital (`cardio:org-beijing-tongren-hospital`)
- Registry lists this organization as a collaborator: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)

## Provenance

Content hash: 4a292abf33ca1cbf2050eac84d07051d6cab0e032adcf343958b23b1d675b52d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
